Derek Riley

Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.

Xantrex Technology, Inc. manufactures power supplies. It specializes in charger and inverter, power inverter, battery charger and backup power. The company is headquartered in Burnaby, Canada.

Fasken Martineau DuMoulin LLP operates as law firm. It provides legal services to construction, financial, insurance, life sciences, corporate, and commercial industry. It offers Labour employment and human rights, litigation and dispute resolution, and privacy and cybersecurity risk management. The company was founded in 1863 and is headquartered in Toronto, Canada.

AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada.

BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada.

Diabetes Canada operates as a registered national charitable organization that is making the invisible epidemic of diabetes visible and urgent. The firm partners with Canadians to end diabetes through educational programs and support services, resources for health-care professionals, advocacy to governments, schools and workplaces and funding Canadian research. The company was founded by Charles Best in 1953 and is headquartered in Toronto, Canada.

Canadian Stroke Network operates as a non-profit healthcare organization. The company was founded in 1999 and is headquartered in Ottawa, Canada.

5WH Leadership engages in the provision of leadership development with training and coaching programs. The company is headquartered in Burlington, Canada.

eSight Corp. manufactures and sells electronic eyewear. The firm offers binocular, OLED color display that fits over prescription lenses, accelerometers, gyroscope, IR range finder and temperature sensor. The company was founded by Conrad W. Lewis in 2006 and is headquartered in Toronto, Canada.

Armour Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development of a new class of anti-hormone therapeutics for the treatment of reproductive tissue-based cancers. The company was founded by Josh Silvertown in 2009 and is headquartered in Toronto, Canada.

Venus Concept Ltd. provides procedural medical devices for aesthetic procedures. The firm specializes in advanced non-surgical platforms for body contouring, skin tightening, cellulite and scar reduction, skin resurfacing, skin rejuvenation, acne reduction, and hair removal. The company was founded by Domenic Serafino, Oded Ron-Edoute, and Orit Fishgold Ron-Edoute and is headquartered in Toronto, Canada.

Fight Against Cancer Innovation Trust is a venture capital firm founded in 2014. The firm is headquartered in Toronto, Canada.

Venus Concept USA, Inc. provides non-surgical aesthetic equipment to physicians and clinics for body contouring, skin tightening, and cellulite reduction. The company is headquartered in Weston, FL.

Scientus Pharma, Inc. provides biopharmaceutical products extracted from the cannabis plant. The private company is based in Whitby, Canada.

Part of BlackRock, Inc., Grosvenor Ventures Ltd. is a British company that provides investment services. The company is based in London, UK. Gregory Gubitz has been the CEO of the company since 2007.

Mirador Global LP provides consulting services to specialty diseases. It provides drug commercialization assessment and launch planning services in Oncology, Immuno-Oncology, Orphan and CNS for small and medium-sized bio-pharma companies around the world. The company was founded by Chuck Peipher in 2016 and is headquartered in Kennett Square, PA.

Part of Eversana Life Science Services LLC, Accelera Canada Ltd. is a full-service firm providing end-to-end commercialization for emerging biotechnology and life science ventures. The company is based in Toronto, Canada. Accelera Canada was acquired by Eversana Life Science Services LLC on July 26, 2021. With senior leadership comprised of former pharmaceutical executives with North American and international experience, Accelera is uniquely positioned to provide strategic guidance and support to companies entering the Canadian healthcare market.

FB Dermatology Ltd. is a med-tech company, which focuses on developing and exploring patented bio-photonic technology using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms. Its products include Kleresca acne treatment, Kleresca skin rejuvenation, Kleresca rosacea treatment, and Kleresca pre-post Treasureratment. The company is headquartered in Dublin, Ireland.

Venus Concept Canada Corp. provides medical and aesthetic technology equipment. The company is headquartered in Toronto, Canada.

Part of Sigmacon Holding SA, Sigmacon (UK) Ltd. is a market leader in innovative technology and high-class laser devices for surgery and ophthalmology. The company is based in Middlesex, UK. Sigmacon supplies a range of ophthalmic products, from SLT lasers to ophthalmic furniture, from brands such as Lumenis and Rini. Founded in 1978, the British company offers an impressive range of products from the world's leading manufacturers, with a focus on providing their customers with the best solutions to meet their clinical requirements.

GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California.

Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016.